Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AVXL - Anavex Life Sciences Corp.
12 M
LAST VALUE
-25.00%
2 YEAR CAGR
-7.60%
5 YEAR CAGR
2.26%
10 YEAR CAGR